Limited efficacy for ibrutinib and venetoclax in T-prolymphocytic leukemia: results from a phase 2 international study

Marco Herling; Claire Dearden; Francesco Zaja; Dima El-Sharkawi; Wei Ding; Mar Bellido; Amit Khot; Lidwine Tick; Eric Jacobsen; Toby A. Eyre; Damien Roos-Weil; Tapan Kadia; Elisa Lucchini; Natali Pflug; Matthew S. Davids; German Pena; Nabanita Mukherjee; Mohamed Badawi; Tamas Vizkelety; Philipp B. Staber

doi:10.1182/bloodadvances.2023012248

Limited efficacy for ibrutinib and venetoclax in T-prolymphocytic leukemia: results from a phase 2 international study

Marco Herling, Claire Dearden, Francesco Zaja, Dima El-Sharkawi, Wei Ding, Mar Bellido, Amit Khot, Lidwine Tick, Eric Jacobsen, Toby A. Eyre, Damien Roos-Weil, Tapan Kadia, Elisa Lucchini, Natali Pflug, Matthew S. Davids, German Pena, Nabanita Mukherjee, Mohamed Badawi, Tamas Vizkelety, Philipp B. Staber

Leukemia

Research output: Contribution to journal › Letter › peer-review

Original language	English (US)
Pages (from-to)	842-845
Number of pages	4
Journal	Blood Advances
Volume	8
Issue number	4
DOIs	https://doi.org/10.1182/bloodadvances.2023012248
State	Published - Feb 27 2024

ASJC Scopus subject areas

Hematology

Access to Document

10.1182/bloodadvances.2023012248

Cite this

Herling, M., Dearden, C., Zaja, F., El-Sharkawi, D., Ding, W., Bellido, M., Khot, A., Tick, L., Jacobsen, E., Eyre, T. A., Roos-Weil, D., Kadia, T., Lucchini, E., Pflug, N., Davids, M. S., Pena, G., Mukherjee, N., Badawi, M., Vizkelety, T., & Staber, P. B. (2024). Limited efficacy for ibrutinib and venetoclax in T-prolymphocytic leukemia: results from a phase 2 international study. Blood Advances, 8(4), 842-845. https://doi.org/10.1182/bloodadvances.2023012248

Herling, M, Dearden, C, Zaja, F, El-Sharkawi, D, Ding, W, Bellido, M, Khot, A, Tick, L, Jacobsen, E, Eyre, TA, Roos-Weil, D, Kadia, T, Lucchini, E, Pflug, N, Davids, MS, Pena, G, Mukherjee, N, Badawi, M, Vizkelety, T & Staber, PB 2024, 'Limited efficacy for ibrutinib and venetoclax in T-prolymphocytic leukemia: results from a phase 2 international study', Blood Advances, vol. 8, no. 4, pp. 842-845. https://doi.org/10.1182/bloodadvances.2023012248

@article{7e1401135cf24c6ca3e14533408533f9,

title = "Limited efficacy for ibrutinib and venetoclax in T-prolymphocytic leukemia: results from a phase 2 international study",

author = "Marco Herling and Claire Dearden and Francesco Zaja and Dima El-Sharkawi and Wei Ding and Mar Bellido and Amit Khot and Lidwine Tick and Eric Jacobsen and Eyre, {Toby A.} and Damien Roos-Weil and Tapan Kadia and Elisa Lucchini and Natali Pflug and Davids, {Matthew S.} and German Pena and Nabanita Mukherjee and Mohamed Badawi and Tamas Vizkelety and Staber, {Philipp B.}",

year = "2024",

month = feb,

day = "27",

doi = "10.1182/bloodadvances.2023012248",

language = "English (US)",

volume = "8",

pages = "842--845",

journal = "Blood Advances",

issn = "2473-9529",

publisher = "American Society of Hematology",

number = "4",

}

TY - JOUR

T1 - Limited efficacy for ibrutinib and venetoclax in T-prolymphocytic leukemia

T2 - results from a phase 2 international study

AU - Herling, Marco

AU - Dearden, Claire

AU - Zaja, Francesco

AU - El-Sharkawi, Dima

AU - Ding, Wei

AU - Bellido, Mar

AU - Khot, Amit

AU - Tick, Lidwine

AU - Jacobsen, Eric

AU - Eyre, Toby A.

AU - Roos-Weil, Damien

AU - Kadia, Tapan

AU - Lucchini, Elisa

AU - Pflug, Natali

AU - Davids, Matthew S.

AU - Pena, German

AU - Mukherjee, Nabanita

AU - Badawi, Mohamed

AU - Vizkelety, Tamas

AU - Staber, Philipp B.

PY - 2024/2/27

Y1 - 2024/2/27

UR - http://www.scopus.com/inward/record.url?scp=85186751245&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85186751245&partnerID=8YFLogxK

U2 - 10.1182/bloodadvances.2023012248

DO - 10.1182/bloodadvances.2023012248

M3 - Letter

C2 - 38190628

AN - SCOPUS:85186751245

SN - 2473-9529

VL - 8

SP - 842

EP - 845

JO - Blood Advances

JF - Blood Advances

IS - 4

ER -

Limited efficacy for ibrutinib and venetoclax in T-prolymphocytic leukemia: results from a phase 2 international study

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this